Go to the list of all blogs
Allana's Avatar
published in Blogs
Jul 10, 2026
Why Is Fermi Inc. (FRMI) Stock Down -16.26% Today?

Why Is Fermi Inc. (FRMI) Stock Down -16.26% Today?

Key Takeaways

  • FRMI shares plunged 16.26% in Friday's session, falling to $6.13 from a prior close of $7.32, as investors reacted to a dilutive convertible notes offering priced after Thursday's close.
  • The primary catalyst is the pricing of an upsized $375 million convertible senior notes offering due 2031, which raised concerns about shareholder dilution and the company's ongoing need for external capital.
  • Secondary pressure stems from the mechanics of capped call hedging, where counterparties may short shares to establish delta-neutral positions, adding near-term selling pressure.
  • The broader pre-revenue energy infrastructure sector remains under scrutiny, and Fermi's ongoing governance disputes with its former CEO continue to weigh on sentiment.
  • Traders are now watching for any tenant or joint-venture announcements, the appointment of a permanent CEO, and the company's next quarterly filing for updated cash-burn metrics.

Opening Summary

Fermi Inc. (FRMI), the Texas-based developer of next-generation private electric grids designed to power hyperscale AI computing, saw its shares tumble 16.26% on Friday. The stock traded at $6.13 as of mid-afternoon, down sharply from Thursday's closing price of $7.32. The sell-off was triggered by the company's announcement late Thursday that it had priced an upsized $375 million convertible senior notes offering, a move that reignited investor concerns about dilution, capital needs, and the pre-revenue company's path to commercial viability.

Convertible Notes Offering Fuels the Sell-Off

The immediate trigger for Friday's decline was Fermi's pricing of a $375 million convertible senior notes offering due 2031, upsized from an initially proposed $350 million. The notes carry a 5.00% annual coupon and an initial conversion price of approximately $9.52 per share, representing a 30% premium to Thursday's close. While the company also entered into capped call transactions that raise the effective dilution threshold to $14.64 per share, the market focused on the negative implications: the addition of $375 million in senior unsecured debt to a balance sheet that already carried roughly $439 million in total indebtedness as of March 31, 2026, and the potential for future equity dilution if the stock recovers above the conversion price.

Convertible note offerings frequently pressure a stock in the near term for several reasons. First, the option counterparties that sell the capped calls typically hedge their exposure by shorting the underlying stock, creating immediate selling pressure. Second, the very act of raising capital through a convertible structure can signal to the market that a company's cash position requires reinforcement. Fermi disclosed that as of June 30, 2026, it held just $92.0 million in cash and cash equivalents, of which $29.2 million was restricted, underscoring the liquidity imperative behind the offering.

Governance Overhang and Pre-Revenue Risk

Beyond the mechanics of the convertible offering, FRMI continues to navigate a complex governance landscape. Former CEO and co-founder Toby Neugebauer, who was terminated for cause in April 2026, recently suspended a proxy campaign to call a special shareholder meeting after failing to secure sufficient support. While the company declared the proxy fight "over" on July 7, the underlying litigation between Neugebauer and the company remains active in Texas business court. The ongoing legal battle creates uncertainty around board composition and strategic direction, and the company's own SEC filings warn that these disputes could "adversely affect our business, operating results and financial condition."

Compounding the governance overhang is Fermi's pre-revenue status. The company has yet to sign a binding tenant agreement for its flagship Project Matador campus in Amarillo, Texas, though management has stated it is in advanced negotiations with select counterparties and expects to announce a deal in the third quarter of 2026. Until a tenant is secured, investors are being asked to fund a capital-intensive infrastructure buildout without visibility on the revenue stream that will ultimately service the growing debt load.

Market Context and Trading Activity

Friday's sell-off occurred on elevated volume, consistent with a market-wide repricing of the stock following the convertible note announcement. The decline pushed FRMI well below its 20-day and 50-day moving averages, and the stock is now trading at levels not seen since mid-June. The move was largely company-specific; broader equity indices were modestly positive during the session, and specialty REIT peers did not exhibit similar weakness, confirming that the convertible offering—not sector or macro forces—drove the price action.

Short interest in FRMI stood at approximately 11.5% of the float as of mid-June, a moderately elevated level that can amplify downward moves when negative catalysts emerge. The hedging activity associated with the convertible notes may have added to the selling pressure, as option counterparties established short positions to offset their exposure under the capped call agreements.

Trending AI Robots

In volatile market environments like the one affecting FRMI today, traders often turn to automated strategies to navigate sharp price swings with discipline. Tickeron's Trending AI Robots page features a curated selection of AI-powered trading bots that have demonstrated strong performance under current market conditions. With hundreds of bots covering thousands of tickers across multiple strategies, timeframes, and performance metrics, the platform highlights only those algorithms that are currently excelling. Each bot operates with a distinct approach—some specialize in momentum, others in mean reversion or volatility-based signals—giving traders a diverse toolkit for managing risk and identifying opportunity. Explore the Trending AI Robots page to see which strategies are leading the market right now.

What Comes Next for FRMI

The path forward for FRMI hinges on several near-term milestones. The company has guided that it expects to sign its first binding joint-venture partner or tenant agreement in the third quarter of 2026, an announcement that would represent a significant de-risking event for the stock. Additionally, Fermi is in advanced discussions to hire a permanent CEO, a move that could help stabilize the leadership vacuum created by Neugebauer's departure and reassure both tenants and financing partners.

On the financial front, the convertible notes are expected to close on July 14, 2026, providing approximately $362 million in net proceeds. How quickly and effectively the company deploys that capital toward turbine installation, site development, and permitting will be closely watched. The company's next earnings report, estimated for August 11, 2026, will offer a critical update on cash burn, construction progress, and any commercial developments. Risks remain substantial: failure to secure a tenant, further governance disruptions, cost overruns on Project Matador, or an inability to access additional capital could all pressure the stock further. Conversely, a credible tenant announcement or progress toward the Department of Energy's Energy Dominance Financing program could shift sentiment rapidly.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: FRMI

Contributor

Allana's AvatarAllana|Expert

Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.


FRMI in downward trend: 10-day moving average crossed below 50-day moving average on July 17, 2026

The 10-day moving average for FRMI crossed bearishly below the 50-day moving average on July 17, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 1 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FRMI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for FRMI entered a downward trend on August 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 7 cases where FRMI's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on August 11, 2026. You may want to consider a long position or call options on FRMI as a result. In of 12 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for FRMI just turned positive on August 11, 2026. Looking at past instances where FRMI's MACD turned positive, the stock continued to rise in of 5 cases over the following month. The odds of a continued upward trend are .

FRMI moved above its 50-day moving average on August 11, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where FRMI advanced for three days, in of 39 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.523) is normal, around the industry mean (103.616). P/E Ratio (0.000) is within average values for comparable stocks, (60.413). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.187). FRMI's Dividend Yield (0.000) is considerably lower than the industry average of (0.045). FRMI's P/S Ratio (0.000) is slightly lower than the industry average of (6.586).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. FRMI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FRMI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock worse than average.

Notable companies

The most notable companies in this group are American Tower Corp (NYSE:AMT).

Industry description

Companies belonging to the specialty telecommunications sector provide voice and data transmission via a single method, such as fixed lines, digital subscriber lines (DSL), wireless technology, the internet or competitive local exchange carriers. Telefonica, Liberty Broadband Corp., and Zayo Group Holdings, Inc. are some of the big specialty telecom companies in the U.S.

Market Cap

The average market capitalization across the Specialty Telecommunications Industry is 21.61B. The market cap for tickers in the group ranges from 2.04K to 105.5B. EQIX holds the highest valuation in this group at 105.5B. The lowest valued company is CWTC at 2.04K.

High and low price notable news

The average weekly price growth across all stocks in the Specialty Telecommunications Industry was 0%. For the same Industry, the average monthly price growth was -0%, and the average quarterly price growth was 0%. FRMI experienced the highest price growth at 13%, while UNIT experienced the biggest fall at -8%.

Volume

The average weekly volume growth across all stocks in the Specialty Telecommunications Industry was 14%. For the same stocks of the Industry, the average monthly volume growth was -53% and the average quarterly volume growth was -15%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 43
P/E Growth Rating: 69
Price Growth Rating: 55
SMR Rating: 69
Profit Risk Rating: 78
Seasonality Score: -24 (-100 ... +100)
View a ticker or compare two or three
FRMI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry SpecialtyTelecommunications

Profile
Details
Interact to see
Advertisement
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Why Is Fermi Inc. (FRMI) Stock Down -16.26% Today?